Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

Times are shown in your local time zone GMT
Speaker Profile Image

A/Prof Alicia Morgans

Dana-Farber Cancer Institute

Professional Bio

Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications.  Her work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense.  She is a member of the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association, and is a member of the cardio-oncology committee of American Heart Association.  Since 2016, she has been the President of the Medical Advisory Board for ZERO, a non-profit organization dedicated to supporting education and research funding for prostate cancer research.

A/Prof Alicia's Presentations

View Program
Panel Discussion
Meeting Room 103
Panel Discussion moderated by Dr Briony Norris & Prof Nathan Lawrentschuk

Invited Presentation
Meeting Room 103
Treatment paradigm in CRPC